Sofinnova Ventures as of Sept. 30, 2018
Portfolio Holdings for Sofinnova Ventures
Sofinnova Ventures holds 60 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A S (ASND) | 16.9 | $176M | 2.5M | 70.86 | |
| Nucana Biomed ordinary shares | 9.6 | $100M | 4.0M | 24.92 | |
| Obseva Sa | 8.2 | $86M | 4.7M | 18.03 | |
| Natera (NTRA) | 7.1 | $74M | 3.1M | 23.94 | |
| Principia Biopharma | 5.8 | $60M | 2.1M | 29.22 | |
| Y Mabs Therapeutics (YMAB) | 5.4 | $56M | 2.1M | 26.56 | |
| Coherus Biosciences (CHRS) | 4.5 | $47M | 2.9M | 16.50 | |
| Merus N V (MRUS) | 3.7 | $39M | 2.0M | 19.74 | |
| Audentes Therapeutics | 3.6 | $37M | 934k | 39.59 | |
| Spark Therapeutics | 2.5 | $26M | 481k | 54.55 | |
| Kiniksa Pharmaceuticals (KNSA) | 2.3 | $24M | 923k | 25.50 | |
| Aclaris Therapeutics (ACRS) | 2.1 | $22M | 1.5M | 14.52 | |
| Sanofi-Aventis SA (SNY) | 1.8 | $18M | 413k | 44.68 | |
| Allergan | 1.8 | $18M | 96k | 190.48 | |
| AstraZeneca (AZN) | 1.6 | $17M | 434k | 39.57 | |
| Nucana Plc american depositary shares (NCNA) | 1.6 | $17M | 667k | 24.92 | |
| Puma Biotechnology (PBYI) | 1.5 | $15M | 337k | 45.85 | |
| Entasis Therapeutics Holdings Ord | 1.2 | $13M | 1.2M | 10.88 | |
| Iterum Therapeutics | 1.1 | $11M | 1.7M | 6.62 | |
| Rigel Pharmaceuticals (RIGL) | 1.0 | $11M | 3.3M | 3.21 | |
| Apellis Pharmaceuticals (APLS) | 0.9 | $9.8M | 550k | 17.78 | |
| Heron Therapeutics (HRTX) | 0.9 | $9.4M | 296k | 31.65 | |
| Alexion Pharmaceuticals | 0.9 | $9.1M | 65k | 138.97 | |
| Tesaro | 0.8 | $8.7M | 224k | 39.01 | |
| Synlogic | 0.8 | $8.2M | 575k | 14.21 | |
| Savara (SVRA) | 0.8 | $7.8M | 698k | 11.16 | |
| Exelixis (EXEL) | 0.7 | $7.1M | 404k | 17.71 | |
| Adamas Pharmaceuticals | 0.7 | $6.9M | 346k | 20.02 | |
| Anaptysbio Inc Common (ANAB) | 0.7 | $6.9M | 70k | 99.82 | |
| Chiasma | 0.6 | $6.4M | 1.8M | 3.60 | |
| Kadmon Hldgs | 0.6 | $6.2M | 1.8M | 3.34 | |
| Aimmune Therapeutics | 0.6 | $6.1M | 222k | 27.28 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.6 | $5.9M | 1.5M | 3.78 | |
| Amicus Therapeutics (FOLD) | 0.5 | $5.4M | 446k | 12.10 | |
| Dermira | 0.5 | $5.4M | 495k | 10.90 | |
| Biohaven Pharmaceutical Holding | 0.5 | $5.0M | 133k | 37.53 | |
| Sarepta Therapeutics (SRPT) | 0.5 | $4.8M | 30k | 161.57 | |
| Rhythm Pharmaceuticals (RYTM) | 0.5 | $4.6M | 159k | 29.15 | |
| Kura Oncology (KURA) | 0.4 | $4.3M | 247k | 17.50 | |
| Blueprint Medicines (BPMC) | 0.4 | $4.0M | 51k | 78.04 | |
| Foamix Pharmaceuticals | 0.4 | $3.8M | 669k | 5.73 | |
| Clearside Biomedical (CLSD) | 0.4 | $3.7M | 607k | 6.15 | |
| Morphosys (MPSYF) | 0.3 | $3.2M | 30k | 106.93 | |
| Molecular Partners (MLLCF) | 0.3 | $3.2M | 145k | 22.41 | |
| Epizyme | 0.3 | $3.1M | 291k | 10.59 | |
| Conatus Pharmaceuticals | 0.3 | $3.1M | 539k | 5.80 | |
| Otonomy | 0.3 | $2.7M | 988k | 2.75 | |
| Edge Therapeutics | 0.2 | $2.3M | 2.9M | 0.82 | |
| Spring Bk Pharmaceuticals In | 0.2 | $2.3M | 190k | 12.06 | |
| ArQule | 0.2 | $2.2M | 386k | 5.66 | |
| Esperion Therapeutics (ESPR) | 0.2 | $1.6M | 37k | 44.34 | |
| Fate Therapeutics (FATE) | 0.2 | $1.7M | 105k | 16.28 | |
| Aduro Biotech | 0.1 | $1.4M | 190k | 7.34 | |
| Syndax Pharmaceuticals (SNDX) | 0.1 | $1.4M | 173k | 8.07 | |
| Adaptimmune Therapeutics (ADAP) | 0.1 | $1.2M | 90k | 13.57 | |
| Histogenics Corp Cmn | 0.1 | $1.1M | 2.1M | 0.55 | |
| Kala Pharmaceuticals | 0.1 | $944k | 96k | 9.87 | |
| Oncomed Pharmaceuticals | 0.1 | $839k | 396k | 2.12 | |
| Amarin Corporation (AMRN) | 0.0 | $0 | 5.2M | 0.00 | |
| Auris Medical Newco Holding Ag Namen-akt Isin Ch0408330303 | 0.0 | $0 | 140k | 0.00 |
